“Sending the Right Signals to the Immune System”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya Smale

MartinWelschofPresImage
Martin Welschof of Opsona Therapeutics  joined us for World Orphan Drug Congress USA 2015 to present about ‘ Sending the Right Signals to the Immune System’. 
Download the presentation now to understand more about:

  • The value of targeting TLRs
  • Opsona’s lead compound OPN-305
  • Efficacy: convincing data in pre-clinical studies
  • OPN-305 Overall Clinical Development Strategy
…and much more!
Get your copy here!
To find out more about   Opsona Therapeutics and OPN-305 , join us at   World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.